2024-2025 / PHAR0003-1

Pharmaceutical tehcnologies and biopharmacy (part II)

Duration

25h Th, 5h SEM

Number of credits

 Master in pharmacy, research focus4 crédits 
 Master in pharmacy, professional focus in conception and development of medicine - bioanalysis4 crédits 
 Master in pharmacy, professional focus in community pharmacy management and professional issues4 crédits 
 Master in pharmacy, professional focus in officinal practice, advice and pharmaceutical follow-up4 crédits 

Lecturer

Brigitte Evrard, Anna Lechanteur

Language(s) of instruction

French language

Organisation and examination

Teaching in the second semester

Schedule

Schedule online

Units courses prerequisite and corequisite

Prerequisite or corequisite units are presented within each program

Learning unit contents

This course is concerned with pharmaceutical forms manufactured in an industrial environment, with a particular focus on the composition and various methods of manufacturing drugs, as well as on the different drug formulation strategies and their repercussions at the biopharmaceutical level.

This teaching unit comprises :

- A theoretical course for which the ptt projected during the course, videos and bibliographical references are available.
- Distance learning seminars (EAD) available according to a timetable that parallels the progress of the subject.

Learning outcomes of the learning unit

The objective of this teaching is the training of the student to the pharmaceutical formulation in terms of composition, manufacture and evaluation based on physicochemical and biopharmaceutical knowledge previously acquired. The purpose of it is to familiarize the student with the marketed pharmaceutical products This course is devoted to the description of the dosage forms manufactured in pharmaceutical industry while insisting again on the indissociable character of the technological and biopharmaceutical aspects. The subjects are the formulation of the solid oral dosage forms (tablet with conventional or modified release, spheroids, stripped forms), transdermic system, pulmonary, intranasal, intraocular, intra-uterin and intravaginal as well as the injectable formulations

More specifically, the learning outcomes targeted by PHAR 0003 (Pharmaceutical Technology and Biopharmacy - part 2) are listed below.

1. Pharmaceutical expertise: mastering and integrating scientific and technical knowledge in terms of the design, formulation and manufacture of pharmaceutical forms and being able to analyse and explain their formulation, structure and biopharmaceutical aspects.
2. Preparation and delivery of medicinal products: Knowing and understanding the main methods of industrial production of medicinal products. Master the aspects relating to the structure and composition of pharmaceutical forms in order to support their delivery by providing judicious advice in terms of administration to the patient.
3. Health advice: Providing sound advice on the optimal use of pharmaceutical forms.
4. Communication: To be able to explain orally the composition of a product on the basis of its formulation and to adapt one's discourse to all interlocutors.
5. Scientific approach: Solve and analyse problems relating to the formulation and design of medicinal products using a critical approach based on a scientific approach. Demonstrate a critical approach to the information accompanying the marketing of new pharmaceutical specialities.
6. Sense of responsibility:
7. Quality: understanding the context of industrial drug production and the environment in which it takes place.

 

 

Prerequisite knowledge and skills

Physico-chemical principles applicated to Pharmaceutical Technology.

Planned learning activities and teaching methods

In line exercices

Mode of delivery (face to face, distance learning, hybrid learning)

Blended learning


Further information:

approximately 2h/week in Q2.

Course materials and recommended or required readings

Lecture notes and the Power Point presentations are available on e-Campus

Exam(s) in session

Any session

- In-person

written exam ( multiple-choice questionnaire ) AND oral exam


Further information:

Oral exam (A)

MCQ online exam (B)

 

The final mark is the weighted average of A (80%) and B (20%).

Students who do not obtain a mark of 10/20 or higher in the written examination will not be admitted to the oral examination.

Work placement(s)

Organisational remarks and main changes to the course

Contacts

B. Evrard, Professeur Ordinaire
Laboratory of Pharmaceutical technology and Biopharmacy, Bât. B36 (niveau 2), 4000 Liège 1 (Sart Tilman)
e-mail : B.Evrard@uliege.be

Secrétariat : 04/366.43.01

Association of one or more MOOCs